Guru Ownership Trend
Guru Analysis for ImmunityBio, Inc. (IBRX)
ImmunityBio, Inc. (IBRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.33 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $313,666.34 net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 21.2%. Conversely, Cliff Asness reduced exposure by 55.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for ImmunityBio, Inc. (IBRX)
Major holders include Renaissance Technologies (RenTech) ($2.44 M), Cliff Asness ($92,317). According to the latest reported data, 2 tracked investment managers collectively hold approximately 1.28 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $313,666.34, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited IBRX. The total reported sell value was $113,164.31.
Yes, 0 managers opened new positions in IBRX, and 1 increased their existing holdings. The total reported buy value was $426,830.65.